Scott Milligan
Head of Analytics at Trio Health- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Trio Health
-
Wellness and Fitness Services
-
1 - 100 Employee
-
Head of Analytics
-
2013 - Present
Trio Health connects key stakeholders in the healthcare continuum for the goal of improving treatment outcomes. The Trio Health solutions suite includes offerings that span from population monitoring to real-world clinical studies to operational applications and best practices. Trio Health connects key stakeholders in the healthcare continuum for the goal of improving treatment outcomes. The Trio Health solutions suite includes offerings that span from population monitoring to real-world clinical studies to operational applications and best practices.
-
-
-
Cardinal Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Director, Clinical Specialty, Specialty Solutions
-
2010 - 2013
Cardinal Health Specialty Solutions provides, among other services, information solutions to drug manufacturers, payers and providers. As Director, I led analysts and account managers in the creation and maintenance of subscription data products and ad hoc analytics. For drug manufacturers, we provided data solutions relied upon by sales groups, brand managers, business development, and market researchers. For payers and providers, we provided analytics in support of Pathways, a program which fostered an effective payer-provider relationship and appropriately incentivized best medical practice.
-
-
-
Leerink Swann
-
United States
-
Investment Banking
-
Director of Analytics and Operations, MEDACorp
-
2009 - 2010
MEDACorp provides consultant expert access and primary market research services internally to Leerink Swann, a healthcare-focused investment bank, and externally to institutional investors. As Director, I managed the MEDACorp team in providing insight to clients for their investment decisions in the healthcare market. MEDACorp provides consultant expert access and primary market research services internally to Leerink Swann, a healthcare-focused investment bank, and externally to institutional investors. As Director, I managed the MEDACorp team in providing insight to clients for their investment decisions in the healthcare market.
-
-
-
IntrinsiQ, LLC
-
United States
-
Advertising Services
-
1 - 100 Employee
-
VP of Analytics
-
2003 - 2009
IntrinsiQ provides oncology market data products and analyses to pharmaceutical and biotechnology companies and institutional investors. In addition to being responsible for the accuracy of 3000+ subscription products each month, my reports generated all in-depth analytics (e.g. risk modeling, clinical trial feasibility, market opportunity analyses, and therapy growth strategies). IntrinsiQ provides oncology market data products and analyses to pharmaceutical and biotechnology companies and institutional investors. In addition to being responsible for the accuracy of 3000+ subscription products each month, my reports generated all in-depth analytics (e.g. risk modeling, clinical trial feasibility, market opportunity analyses, and therapy growth strategies).
-
-
-
MORPACE International
-
United Kingdom
-
Market Research
-
Director of Oncology, Morpace Pharma Group
-
2001 - 2003
A subsidiary of MORPACE International, Morpace Pharma created multi-country market models for scenario analyses of pipeline and newly launched therapies. I directed my team in producing dozens of distinct cancer models, each the culmination of medical practice surveys, physician-preference conjoint surveys, thought-leader interviews, 10-year epidemiology forecasts, and detailed pricing analyses. A subsidiary of MORPACE International, Morpace Pharma created multi-country market models for scenario analyses of pipeline and newly launched therapies. I directed my team in producing dozens of distinct cancer models, each the culmination of medical practice surveys, physician-preference conjoint surveys, thought-leader interviews, 10-year epidemiology forecasts, and detailed pricing analyses.
-
-
-
Dana-Farber Cancer Institute
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Postgraduate Research
-
1997 - 2001
Postdoctoral research in the Pellman lab that examined the roles of various proteins in cell proliferation. Postdoctoral research in the Pellman lab that examined the roles of various proteins in cell proliferation.
-
-
Education
-
University of Notre Dame
PhD, Biology -
Butler University
BS, Biology